Lifeward CEO Mark Grant addressed the 53 rd ASIA Annual Scientific Meeting audience with a speech regarding Lifeward and its vision for restoring full function to people living with spinal cord ...

HUDSON, Mass., and YOKNEAM ILLIT, Israel, May 04, 2026 (GLOBE NEWSWIRE)-- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the ...

Global data since 2013 show just 3% lifetime fracture prevalence, declining to 0.3% over the past six years Zero fractures reported across 97 German users since 2018, spanning broad patient profiles ...

Oramed strategic transactionsuccessfully closed and $10 million financing received Oratech acquisition brings $6.5 million in cash and promisingProtein Oral Delivery™ biomed technology, with lead ...

Oramed Pharmaceuticals is downgraded to Hold due to the failed phase 3 trial for ORMD-0801 in Type 2 Diabetes. Read more on ...

Lifeward Ltd (LFWD) reports a revenue dip amid supply chain issues but strengthens its position with strategic acquisitions and financing.

HUDSON, Mass. and YOKNEAM ILLIT, Israel, May 11, 2026 (GLOBE NEWSWIRE)-- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of ...

Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease ...

Lifeward expects efficiencies in marketing and sales to continue reducing core operating expenses, with increased R&D ...

After a devastating 2014 cycling accident left Doug Rogers paralyzed from the chest down, he’s continued setting new ...